The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
The Genetics of Osteosarcoma
Open accessAbstract
Osteosarcoma is a primary bone malignancy with a particularly high incidence rate in children and adolescents relative to other age groups. The etiology of this often aggressive cancer is currently unknown, because complicated structural and numeric genomic rearrangements in cancer cells preclude understanding of tumour development. In addition, few consistent genetic changes that may indicate effective molecular therapeutic targets have been reported. However, high-resolution techniques continue to improve knowledge of distinct areas of the genome that are more commonly associated with osteosarcomas. Copy number gains at chromosomes 1p, 1q, 6p, 8q, and 17p as well as copy number losses at chromosomes 3q, 6q, 9, 10, 13, 17p, and 18q have been detected by numerous groups, but definitive oncogenes or tumour suppressor genes remain elusive with respect to many loci. In this paper, we examine studies of the genetics of osteosarcoma to comprehensively describe the heterogeneity and complexity of this cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“CIN is the elevated rate of gain or loss of entire chromosomes or sections of chromosomes [16, 18], and it appears to be significant in the pathogenesis of osteosarcoma tumours, resulting in complicated structural and numerical aberrations and wide variability between cells [19].”
BackgroundGerm Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,486
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Role of telomeres and telomerase in cancer
Shay, J. W., & Wright, W. E. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.001 · Cited by 523
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
Henson, J. D., Cao, Y., Huschtscha, L. I., Chang, A. C., Au, A. Y. M., Pickett, H. A., & Reddel, R. R. (2009) · Nature Biotechnology · doi:10.1038/nbt.1587 · Cited by 498
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML Factors
Lian, J. B., Javed, A., Zaidi, S. K., Lengner, C., Montecino, M., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.10 · Cited by 442
Excess of rare cancers in Werner syndrome (adult progeria).
Goto, M., Miller, R. W., Ishikawa, Y., & Sugano, H. (1996) · PubMed · Cited by 442
German, J. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30101-3 · Cited by 422
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition.
Hansen, M. F., Koufos, A., Gallie, B. L., Phillips, R. A., Fodstad, O., Brøgger, A., Gedde-Dahl, T., & Cavenee, W. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6216 · Cited by 415
Walkley, C. R., Qudsi, R., Sankaran, V. G., Perry, J. A., Gostissa, M., Roth, S. I., Rodda, S. J., Snay, E., Dunning, P., Fahey, F. H., et al. (2008) · Genes & Development · doi:10.1101/gad.1656808 · Cited by 373
Defining ‘chromosomal instability’
Geigl, J. B., Obenauf, A. C., Schwarzbraun, T., & Speicher, M. R. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.006 · Cited by 341
MDM2 gene amplification in metastatic osteosarcoma.
Ladanyi, M., Cha, C. H., Lewis, R., Jhanwar, S. C., Huvos, A. G., & Healey, J. H. (1993) · PubMed · Cited by 340
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Bloom's syndrome. XX. The first 100 cancers
German, J. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00336-6 · Cited by 317
Henson, J. D., Hannay, J. A., McCarthy, S. W., Royds, J. A., Yeager, T. R., Robinson, R. A., Wharton, S. B., Jellinek, D. A., Arbuckle, S. M., Yoo, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.217.11.1 · Cited by 305
Using Epidemiology and Genomics to Understand Osteosarcoma Etiology
Savage, S. A., & Mirabello, L. (2011) · Sarcoma · doi:10.1155/2011/548151 · Cited by 303
Mohseny, A. B., Szuhai, K., Romeo, S., Buddingh, E. P., Briaire‐de Bruijn, I., de Jong, D., van Pel, M., Cleton‐Jansen, A., & Hogendoorn, P. C. (2009) · The Journal of Pathology · doi:10.1002/path.2603 · Cited by 269
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Fuchs, B., & Pritchard, D. J. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00007 · Cited by 248
Dujardin, F., Binh, M. B. N., Bouvier, C., Gomez-Brouchet, A., Larousserie, F., Muret, A. D., Louis-Brennetot, C., Aurias, A., Coindre, J.-M., Guillou, L., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.229 · Cited by 243
DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders
Mohaghegh, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.741 · Cited by 229
Osteosarcoma in Paget's Disease of Bone
Hansen, M. F., Seton, M., & Merchant, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s211 · Cited by 212
Frequency and structure of p53 rearrangements in human osteosarcoma.
Miller, C. W., Aslo, A., Tsay, C., Slamon, D. J., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B. C., & Koeffler, H. P. (1990) · PubMed · Cited by 210
Ulaner, G. A., Huang, H.-Y., Otero, J. E., Zhao, Z., Ben‐Porat, L., Satagopan, J. M., Gorlick, R. G., Meyers, P. A., Healey, J. H., Huvos, A. G., et al. (2003) · PubMed · Cited by 210
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
PosthumaDeBoer, J., Witlox, M. A., Kaspers, G. J. L., & van Royen, B. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9384-x · Cited by 194
Overholtzer, M., Rao, P. H., Favis, R., Lu, X.-Y., Elowitz, M. B., Barany, F., Ladanyi, M., Gorlick, R., & Levine, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934852100 · Cited by 193
Alterations of thep53, Rb andMDM2 genes in osteosarcoms
Miller, C. W., Aslo, A., Won, A., Tan, M., Lampkin, B., & Koefflar, H. P. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213553 · Cited by 190
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas
Scheel, C., Schaefer, K.-L., Jauch, A., Keller, M., Wai, D., Brinkschmidt, C., van Valen, F., Boecker, W., Dockhorn-Dworniczak, B., & Poremba, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204493 · Cited by 182
Tsuchiya, T., Sekine, K.-I., Hinohara, S.-I., Namiki, T., Nobori, T., & Kaneko, Y. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00255-1 · Cited by 179
Prognostic factors in localized extremity osteosarcoma: A systematic review
Bramer, J. A. M., van Linge, J. H., Grimer, R. J., & Scholten, R. J. P. M. (2009) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2009.01.011 · Cited by 177
Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization.
Tarkkanen, M., Karhu, R., Kallioniemi, A. H., et al. (1995) · PubMed · Cited by 171
Pasic, I., Shlien, A., Durbin, A. D., Stavropoulos, D. J., Baskin, B., Ray, P. N., Novokmet, A., & Malkin, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1902 · Cited by 171
Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature
Bridge, J. A., Nelson, M., McComb, E., McGuire, M. H., Rosenthal, H., Vergara, G., Maale, G. E., Spanier, S., & Neff, J. R. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00306-8 · Cited by 171
Genomic mechanisms and measurement of structural and numerical instability in cancer cells
Bayani, J., Selvarajah, S., Maire, G., Vukovic, B., Al-Romaih, K. I., Zieleńska, M., & Squire, J. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.006 · Cited by 170
Self-citationAmplification and Expression of Cyclin D Genes (CCND1 CCND2 and CCND3) in Human Malignant Gliomas
Büschges, R., Weber, R. G., Actor, B., Lichter, P., Collins, V. P., & Reifenberger, G. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00532.x · Cited by 164
Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.
Yamaguchi, T., Toguchida, J., Yamamuro, T., Kotoura, Y., Takada, N., Kawaguchi, N., Kaneko, Y., Nakamura, Y., Sasaki, M. S., & Ishizaki, K. (1992) · PubMed · Cited by 159
Squire, J. A., Pei, J., Marrano, P. M., Beheshti, B., Bayani, J., Lim, G., Moldovan, L., & Zieleńska, M. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10273 · Cited by 159
Self-citationTarkkanen, M., Elomaa, I., BLOMQVIST, C. P., Kivioja, A., Kellokumpu‐Lehtinen, P., B�hling, T., Valle, J., & Knuutila, S. (1999) · International Journal of Cancer · Cited by 150
Genetic instability in cancer: Theory and experiment
BECKMAN, R., & Loeb, L. A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.007 · Cited by 150
Man, T., Lu, X.-Y., Jaeweon, K., Perlaky, L., Harris, C. P., Shah, S. K., Ladanyi, M., Gorlick, R. G., Lau, C. C., & Rao, P. H. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-45 · Cited by 149
p53 and MDM2 alterations in osteosarcomas
Lonardo, F., Ueda, T., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8<1541::aid-cncr15>3.0.co;2-y · Cited by 147
Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcoma
Lau, C. C., Harris, C. P., Lu, X., Perlaky, L., Gogineni, S. K., Chintagumpala, M., Hicks, J. M., Johnson, M. E., Davino, N. A., Huvos, A. G., et al. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10291 · Cited by 146
Forus, A., Weghuis, D. O., Smeets, D., Fodstad, Ø., Myklebost, O., & van Kessel, A. G. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140104 · Cited by 142
Identification of Differentially Expressed MicroRNAs in Osteosarcoma
Lulla, R. R., Costa, F. F., Bischof, J. M., Chou, P. M., Bonaldo, M. F., Vanin, E. F., & Soares, M. B. (2011) · Sarcoma · doi:10.1155/2011/732690 · Cited by 141
Sadiković, B., Yoshimoto, M., Chilton‐MacNeill, S., Thorner, P. S., Squire, J. A., & Zieleńska, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp117 · Cited by 141
Self-citationHaslam, S. I., Hul, W. V., Morales-Piga, A. A., Balemans, W., San-Millan, J. L., Nakatsuka, K., Willems, P. J., Kingsbury, N., & Ralston, S. H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.911 · Cited by 138
Sadiković, B., Thorner, P. S., Chilton‐MacNeill, S., Martin, J. W., Cervigne, N. K., Squire, J. A., & Zieleńska, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-202 · Cited by 138
Self-citationMitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressivePreprint
Coschi, C. H., Martens, A. L., Ritchie, K., Francis, S. M., Chakrabarti, S., Bérubé, N. G., & Dick, F. A. (2010) · Genes & Development · doi:10.1101/gad.1917610 · Cited by 132
Loss of Rb proteins causes genomic instability in the absence of mitogenic signalingPreprint
van Harn, T., Foijer, F., van Vugt, M. A. T. M., Banerjee, R., Yang, F., Oostra, A. B., Joenje, H., & Riele, H. T. (2010) · Genes & Development · doi:10.1101/gad.580710 · Cited by 132
Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Gökgöz, N., Wunder, J. S., Mousses, S., Eskandarian, S., Bell, R. S., & Andrulis, I. L. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3 · Cited by 131
Olsson, A. Y., Feber, A., Edwards, S. E., Poele, R. T., Giddings, I., Merson, S., & Cooper, C. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209854 · Cited by 130
Maire, G., Martin, J. W., Yoshimoto, M., Chilton‐MacNeill, S., Zieleńska, M., & Squire, J. A. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2010.12.012 · Cited by 130
Self-citationGene amplifications in osteosarcoma—CGH microarray analysis
Atiye, J., Wolf, M., Kaur, S., Monni, O. M., Böhling, T., Kivioja, A., Tas, É., Serra, M., Tarkkanen, M., & Knuutila, S. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20120 · Cited by 130
Bayani, J., Zieleńska, M., Pandita, A., Al-Romaih, K. I., Karásková, J., Harrison, K. J., Bridge, J. A., Sorensen, P. H. B., Thorner, P. S., & Squire, J. A. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10132 · Cited by 127
Self-citationYang, J., Yang, D., Sun, Y. K., Sun, B., Wang, G., Trent, J. C., Araujo, D. M., Chen, K., & Zhang, W. (2011) · Cancer · doi:10.1002/cncr.26116 · Cited by 125
Mejia‐Guerrero, S., Quejada, M., Gokgoz, N., Gill, M., Parkes, R. K., Wunder, J. S., & Andrulis, I. L. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20761 · Cited by 120 · cited 2×
“Amplification of MDM2 (chromosome 12q15) is a relatively infrequent event in primary osteosarcoma, occurring in 3–25% of tumours [47, 48, 57, 72, 73] but appears to be considerably more frequent in metastases and recurrences [47, 73, 74].”
BackgroundGenomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
Smida, J., Baumhoer, D., Rosemann, M., Walch, A. K., Bielack, S., Poremba, C., REMBERGER, K., Korsching, E., Scheurlen, W. G., Dierkes, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0284 · Cited by 115
Chromosomal regions involved in the pathogenesis of osteosarcomas
Stock, C., Kager, L., Fink, F., Gadner, H., & Ambros, P. F. (2000) · Genes Chromosomes and Cancer · Cited by 113
Kurek, K. C., Mare, S. D., Salah, Z., Abdeen, S. K., Sadiq, H., Lee, S.-H., Gaudio, E., Zanesi, N. A. O., Jones, K. B., DeYoung, B. R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4602 · Cited by 112
CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations
Nielsen, G. P., Burns, K. L., Rosenberg, A. E., & Louis, D. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65556-3 · Cited by 111
Nellissery, M. J., Padalecki, S. S., Brkanac, Z., Singer, F. R., Roodman, G. D., Unni, K. K., Leach, R. J., & Hansen, M. F. (1998) · The American Journal of Human Genetics · doi:10.1086/302019 · Cited by 110
Telomerase Expression Predicts Unfavorable Outcome in Osteosarcoma
Sanders, R. P., Drissi, R., Billups, C. A., Daw, N. C., Valentine, M. B., & Dome, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.043 · Cited by 110
Hurst, C. D., Tomlinson, D. C., Williams, S. V., Platt, F. M., & Knowles, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210934 · Cited by 108
Szymanska, J., Mandahl, N., Mertens, F., Tarkkanen, M., Karaharju, E. O., & Knuutila, S. (1996) · Genes Chromosomes and Cancer · Cited by 104
Alterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 103
Ulaner, G. A., Hoffman, A. R., Otero, J. E., Huang, H., Zhao, Z., Mazumdar, M., Gorlick, R. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20074 · Cited by 102
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas
Ozaki, T., Schaefer, K., Wai, D., Buerger, H., Flege, S., Lindner, N. J., Kevric, M., Diallo, R. I., Bánkfalvi, Á., Brinkschmidt, C., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10709 · Cited by 100
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · PubMed · doi:10.1002/(sici)1097-4644(199610)63:1%3c37::aid-jcb3%3e3.0.co;2-0 · Cited by 98
Montgomery, E. A., Argani, P., Hicks, J. L., Marzo, A. M. D., & Meeker, A. K. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63710-8 · Cited by 98
Kresse, S. H., Ohnstad, H. O., Paulsen, E. B., Bjerkehagen, B., Szuhai, K., Serra, M., Schaefer, K., Myklebost, O., & Meza‐Zepeda, L. A. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20675 · Cited by 97
Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience
Weiss, A. R., Khoury, J. D., Hoffer, F. A., Wu, J., Billups, C. A., Heck, R. K., Quintana, J. A., Poe, D., Rao, B. N., & Daw, N. C. (2007) · Cancer · doi:10.1002/cncr.22574 · Cited by 94
Oncogene alterations in primary, recurrent, and metastatic human bone tumors
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · Journal of Cellular Biochemistry · Cited by 87
Linkage of Paget Disease of Bone to a Novel Region on Human Chromosome 18q23
Good, D. M., Busfield, F., Fletcher, B. H., Duffy, D. L., Kesting, J. B., Andersen, J., & Shaw, J. T. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338658 · Cited by 86
Cell Cycle Regulator Gene CDC5L , a Potential Target for 6p12-p21 Amplicon in Osteosarcoma
Lu, X., Lu, Y., Zhao, Y., Jaeweon, K., Kang, J., Li, X., Ge, G., Meyer, R., Perlaky, L., Hicks, J. M., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2115 · Cited by 86
pRB, a tumor suppressor with a stabilizing presence
Manning, A. L., & Dyson, N. J. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.05.003 · Cited by 84
Kruzelock, R. P., Murphy, E. C., Strong, L. C., Naylor, S. L., & Hansen, M. F. (1997) · PubMed · Cited by 78
Sadiković, B., Yoshimoto, M., Al-Romaih, K. I., Maire, G., Zieleńska, M., & Squire, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002834 · Cited by 77
Self-citationGisselsson, D., Höglund, M., Mertens, F., Mitelman, F., & Mandahl, N. (1998) · Genes Chromosomes and Cancer · Cited by 77
A Mammalian Homolog of Fission Yeast Cdc5 Regulates G2 Progression and Mitotic Entry*
Bernstein, H. S., & Coughlin, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4666 · Cited by 75
Duhamel, L. A., Ye, H., Halai, D., Idowu, B. D., Presneau, N., Tirabosco, R., & Flanagan, A. M. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04023.x · Cited by 75
Comparative genomic hybridization of low-grade central osteosarcoma.
Tarkkanen, M., Böhling, T., Gamberi, G., Ragazzini, P., Ms, B., Kivioja, A., Kallio, P., Elomaa, I., Picci, P., & Knuutila, S. (1998) · PubMed · Cited by 72
Amplification of 17p11.2∼p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma
van Dartel, M., Cornelissen, P. W. A., Redeker, S., Tarkkanen, M., Knuutila, S., Hogendoorn, P. C. W., Westerveld, A., Gomes, I., Bras, J., & Hulsebos, T. J. M. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00627-1 · Cited by 70
Henriksen, J. M., Ågesen, T. H., Mælandsmo, G. M., Lothe, R. A., Myklebost, O., & Forus, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206671 · Cited by 65
Maire, G., Yoshimoto, M., Chilton‐MacNeill, S., Thorner, P. S., Zieleńska, M., & Squire, J. A. (2009) · Neoplasia · doi:10.1593/neo.81384 · Cited by 64
Self-citationFletcher (2009) · International Journal of Oncology · doi:10.3892/ijo_00000390 · Cited by 62
Entz‐Werlé, N., Lavaux, T., Metzger, N., Stoetzel, C., Lasthaus, C., Marec‐Bérard, P., Kalita, C., Brugières, L., Pacquement, H., Schmitt, C., et al. (2007) · Neoplasia · doi:10.1593/neo.07367 · Cited by 60
Patiño‐García, A., Sotillo, E., Díez, M. Z., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200305000-00003 · Cited by 59
COPS3 amplification and clinical outcome in osteosarcoma
Yan, T., Wunder, J. S., Gökgöz, N., Gill, M., Eskandarian, S., Parkes, R. K., Bull, S. B., Bell, R. S., & Andrulis, I. L. (2007) · Cancer · doi:10.1002/cncr.22595 · Cited by 59
Mohseny, A. B., Tieken, C., van der Velden, P. A., Szuhai, K., de Andrea, C., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20817 · Cited by 59
Chromosome analysis of nine osteosarcomas
Hoogerwerf, W. A., Hawkins, A. L., Griffin, C. A., & Perlman, E. J. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870090203 · Cited by 58
Selvarajah, S., Yoshimoto, M., Park, P. C., Maire, G., Paděrová, J., Bayani, J., Lim, G., Al-Romaih, K. I., Squire, J. A., & Zieleńska, M. (2006) · Chromosoma · doi:10.1007/s00412-006-0074-4 · Cited by 58
Self-citationDeletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma
Yang, J., Cogdell, D. E., Yang, D., Hu, L., Li, H., Zheng, H., Du, X., Pang, Y., Trent, J. C., Chen, K., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.018 · Cited by 57
Weiss, M. B., Vitolo, M. I., Mohseni, M., Rosen, D. M., Denmeade, S. R., Park, B. H., Weber, D. J., & Bachman, K. E. (2010) · Oncogene · doi:10.1038/onc.2010.220 · Cited by 54
Analysis of 12q13-15 Genes in Parosteal Osteosarcoma
Gamberi, G., Ragazzini, P., Benassi, M. S., Ferrari, C., Sollazzo, M. R., Molendini, L., Merli, M., Magagnoli, G., Ruggieri, P., Balladelli, A., et al. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200008000-00026 · Cited by 52
Amplification and overexpression of genes in 17p11.2∼p12 in osteosarcoma
van Dartel, M., & Hulsebos, T. J. M. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.03.007 · Cited by 52
L??pez-Guerrero, J. A., L??pez-Gin??s, C., Pell??n, A., Cardá, C., & Llombart‐Bosch, A. (2004) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200406000-00004 · Cited by 52
Cytogenetic Findings in 36 Osteosarcoma Specimens and a Review of the Literature
Boehm, A. K., Neff, J. R., Squire, J. A., et al. (2000) · Fetal and Pediatric Pathology · doi:10.1080/15513810009168645 · Cited by 52
Self-citationAmplifications of DNA primase 1 (PRIM1) in human osteosarcoma
Yotov, W. V., Hamel, H., Rivard, G.-E., Champagne, M. A., Russo, P., Leclerc, J., Bernstein, M. L., & Levy, E. H. (1999) · Genes Chromosomes and Cancer · Cited by 52
Telomere length and variation in telomere biology genes in individuals with osteosarcoma.
Mirabello, L., Richards, E. G., Duong, L. M., Yu, K. F., Wang, Z., Cawthon, R., Berndt, S. I., Burdett, L. A., Chowdhury, S., Teshome, K., et al. (2011) · PubMed · Cited by 50
Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma
Park, H., Jung, W. W., Bertoni, F., Bacchini, P., Park, J. H., Kim, Y.-W., & Park, Y.-K. (2004) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.04.006 · Cited by 48
Roschke, A. V., Glebov, O. K., Lababidi, S., Gehlhaus, K., Weinstein, J. N., & Kirsch, I. R. (2008) · Neoplasia · doi:10.1593/neo.08682 · Cited by 46
Selvarajah, S., Yoshimoto, M., Maire, G., Paděrová, J., Bayani, J., Squire, J. A., & Zieleńska, M. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.08.003 · Cited by 43
Self-citationLundberg, G., Sehic, D., Länsberg, J., Øra, I., Frigyesi, A., Castel, V., Navarro, S., Piqueras, M., Martinsson, T., Noguera, R., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20850 · Cited by 43
Telomere length maintenance – an ALTernative mechanism
Royle, N. J., Foxon, J. L., Jeyapalan, J. N., Méndez-Bermúdez, A., Novo, C. L., Williams, J. P., & Cotton, V. E. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167814 · Cited by 40
Mutation analysis of the RECQL4 gene in sporadic osteosarcomas
Nishijo, K., Nakayama, T., Aoyama, T., Okamoto, T., Ishibe, T., Yasura, K., Shima, Y., Shibata, K. R., Tsuboyama, T., Nakamura, T., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20269 · Cited by 39
Kubista, B., Klinglmueller, F., Bilban, M., Pfeiffer, M., Lass, R., Giurea, A., Funovics, P. T., Toma, C. D., Dominkus, M., Kotz, R. I., et al. (2010) · International Orthopaedics · doi:10.1007/s00264-010-0996-6 · Cited by 38
Heinsohn, S., Evermann, U., Stadt, U. Z., Bielack, S., & Kabisch, H. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.5.1205 · Cited by 35
p53 gene mutations in osteosarcomas of low-grade malignancy
Radig, K., Schneider‐Stock, R., Haeckel, C., Neumann, W., & Roessner, A. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90263-5 · Cited by 33
Transient Activation of the ALT Pathway in Human Primary Fibroblasts Exposed to High-LET Radiation
Berardinelli, F., Antoccia, A., Cherubini, R., Nadal, V. D., Gerardi, S., Cirrone, G. A. P., Tanzarella, C., & Sgura, A. (2010) · Radiation Research · doi:10.1667/rr2127.1 · Cited by 33
Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes
Mendoza, S., David, H., Gaylord, G. M., & Miller, C. W. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.035 · Cited by 28
Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells
van der Poel, H. G., Zevenhoven, J., & Bergman, A. M. (2010) · Urologia Internationalis · doi:10.1159/000277601 · Cited by 28
SAS is amplified predominantly in surface osteosarcoma
Noble-Topham, S. E., Kandel, R. A., Burrow, S. R., Bell, R. S., Eppert, K., Meltzer, P. S., & Andrulis, I. L. (1996) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100140504 · Cited by 28
Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma
Johnson‐Pais, T. L., Nellissery, M. J., Ammerman, D. G., Pathmanathan, D., Bhatia, P., Buller, C. L., Leach, R. J., & Hansen, M. F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11070 · Cited by 23
Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis
Paulson, Q. X., Pusapati, R. V., Hong, S. K., Weaks, R. L., Conti, C. J., & Johnson, D. G. (2008) · Oncogene · doi:10.1038/onc.2008.138 · Cited by 18
Martin, J. W., Yoshimoto, M., Ludkovski, O., Thorner, P. S., Zieleńska, M., Squire, J. A., & Nuin, P. A. S. (2010) · Cytogenetic and Genome Research · doi:10.1159/000308353 · Cited by 17
Self-citation
Cited by
Lindsey, B. A., Markel, J. E., & Kleinerman, E. S. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-016-0050-2 · Cited by 487
Gardner, H. L., Sivaprakasam, K., Briones, N., Zismann, V., Perdigones, N., Drenner, K., Facista, S., Richholt, R., Liang, W., Aldrich, J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0487-2 · Cited by 120
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma
Bayles, I., Krajewska, M., Pontius, W. D., Saiakhova, A., Morrow, J. J., Bartels, C., Lu, J., Faber, Z. J., Fedorov, Y., Hong, E. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127718 · Cited by 46
Rajan, S., Zaccaria, S., Cannon, M. V., Cam, M., Gross, A. C., Raphael, B. J., & Roberts, R. D. (2021) · doi:10.1101/2021.08.30.458268 · Cited by 33
Sarcoma care in the era of precision medicine
Wallander, K., Öfverholm, I., Boye, K., Tsagkozis, P., Papakonstantinou, A., Lin, Y., & Haglund de Flon, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13717 · Cited by 30
Metadata
- Authors
- Martin, J. W., Squire, J. A., & Zielenska, M.
- Venue
- Sarcoma
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1357-714X (ISSN-L)
- 1369-1643
- OpenAlex
- W2077149593
- Cited by
- 252
- References
- 120
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.